Clinical Practice StatementsSubject: LeukoplakiaThe American Academy of Oral Medicine (AAOM) affirms that oral leukoplakia is a condition with malignant potential and is the most common precursor to oral squamous cell carcinoma (SCCa). Its identification requires a thorough history and clinical examination and warrants clinicopathologic correlation. Definitive diagnosis and appropriate management of patients with leukoplakia are necessary for an attempt to reduce the incidence and mortality rates of SCCa.
Subject: Oral Contact AllergyThe American Academy of Oral Medicine (AAOM) affirms that oral contact allergy (OCA) is an oral mucosal response that may be associated with materials and substances found in oral hygiene products, common food items, and topically applied agents. The AAOM also affirms that patients with suspected OCA should be referred to the appropriate dental and/or medical health care provider(s) for comprehensive evaluation and management of the condition. Replacement and/or substitution of dental materials should be considered only if (1) a reasonable temporal association has been established between the suspected triggering material and development of clinical signs and/or symptoms, (2) clinical examination supports an association between the suspected triggering material and objective clinical findings, and (3) diagnostic testing (e.g., dermatologic patch testing, skin-prick testing) confirms a hypersensitivity reaction to the suspected offending material. Originators: Dr. Eric T. Stoopler, DMD, FDS RCSEd, FDS RCSEng, Dr. Scott S. De Rossi, DMD. This Clinical Practice Statement was developed as an educational tool based on expert consensus of the American Academy of Oral Medicine (AAOM) leadership. Readers are encouraged to consider the recommendations in the context of their specific clinical situation, and consult, when appropriate, other sources of clinical, scientific, or regulatory information prior to making a treatment decision. Subject: Dental Evaluation Prior to Head and Neck Radiotherapy With or Without ChemotherapyThe AAOM affirms that risk factor assessment for oral diseases including oral and oropharyngeal cancers, and a non-invasive visual and tactile oral mucosal examination is part of the standard initial and recall visit by oral health care providers and is recommended for all patients. Originator: Dr. Douglas E. Peterson, DMD, Ph.D, FDS RCSEd This Clinical Practice Statement was developed as an educational tool based on expert consensus of the American Academy of Oral Medicine (AAOM) leadership. Readers are encouraged to consider the recommendations in the context of their specific clinical situation, and consult, when appropriate, other sources of clinical, scientific, or regulatory information prior to making a treatment decision. Subject: Dental Care for the Patient with an Oral Herpetic LesionThe AAOM affirms that risk factor assessment for oral diseases including oral and oropharyngeal cancers, and a non-invasive visual and tactile oral mucosal examination is part of the standard initial and recall visit by oral health care providers and is recommended for all patients. Originator: Dr. Craig S. Miller, DMD, MS This Clinical Practice Statement was developed as an educational tool based on expert consensus of the American Academy of Oral Medicine (AAOM) leadership. Readers are encouraged to consider the recommendations in the context of their specific clinical situation, and consult, when appropriate, other sources of clinical, scientific, or regulatory information prior to making a treatment decision. Subject: Oral Cancer ScreeningThe AAOM affirms that risk factor assessment for oral diseases including oral and oropharyngeal cancers, and a non-invasive visual and tactile oral mucosal examination is part of the standard initial and recall visit by oral health care providers and is recommended for all patients. Originator: Dr. Ross Kerr, DDS, MS This Clinical Practice Statement was developed as an educational tool based on expert consensus of the American Academy of Oral Medicine (AAOM) leadership. Readers are encouraged to consider the recommendations in the context of their specific clinical situation, and consult, when appropriate, other sources of clinical, scientific, or regulatory information prior to making a treatment decision. Subject: Medical HistoryThe AAOM affirms that understanding the medical health of dental patients is important for proper dental care and the overall health of the patient. Originator: Dr.Craig Miller, DMD, MS Subject: Risk AssessmentThe AAOM affirms that the patient evaluation process requires inclusion of determination of risk associated with dental treatment. Risk assessment is essential for the delivery of safe and appropriate dental care as well as the overall health of the patient. Originator: Dr. Craig S. Miller, DMD, MS This Clinical Practice Statement was developed as an educational tool based on expert consensus of the American Academy of Oral Medicine (AAOM) leadership. Readers are encouraged to consider the recommendations in the context of their specific clinical situation, and consult, when appropriate, other sources of clinical, scientific, or regulatory information prior to making a treatment decision. Subject: Management of Patients on Warfarin TherapyThe American Academy of Oral Medicine (AAOM) affirms that understanding the appropriate risk assessment and monitoring of patients taking warfarin (Coumadin) is important for safe delivery of dental care and the overall health of the patient. Originator: Dr. Peter B. Lockhart, DDS This Clinical Practice Statement was developed as an educational tool based on expert consensus of the American Academy of Oral Medicine (AAOM) leadership. Readers are encouraged to consider the recommendations in the context of their specific clinical situation, and consult, when appropriate, other sources of clinical, scientific, or regulatory information prior to making a treatment decision. Subject: Clinical Management of Cancer Therapy-Induced Salivary Gland Hypofunction and XerostomiaThe American Academy of Oral Medicine (AAOM) affirms that a thorough medical history and clinical oral examination provide the basis for the appropriate diagnosis and clinical management of salivary gland hypofunction and xerostomia induced by cancer therapy. The goal of therapy is to maximize salivary flow rate, to prevent or minimize the adverse effects of salivary gland hypofunction, and to improve patient masticatory function and comfort. Originator: Dr. Siri Beier Jensen This Clinical Practice Statement was developed as an educational tool based on expert consensus of the AAOM leadership. Readers are encouraged to consider the recommendations in the context of their specific clinical situation and consult, when appropriate, other sources of clinical, scientific, or regulatory information before making a treatment decision. Subject: Oral Lichen Planus and Oral CancerThe American Academy of Oral Medicine (AAOM) affirms that patients with oral lichen planus have an increased risk of developing oral cancer and require careful management and monitoring by appropriately trained clinicians. This Clinical Practice Statement was developed as an educational tool based on expert consensus of the AAOM leadership. Readers are encouraged to consider the recommendations in the context of their specific clinical situation and consult, when appropriate, other sources of clinical, scientific, or regulatory information before making a treatment decision. |
News
- United Healthcare Expands Access to Straticyte™ Test for Oral Cancer Risk Assessment
- Join the Head & Neck Cancer Alliance Move-A-Thon!
- Head and Neck Cancer Alliance Screening Opportunities
- AAOM is once again in the spotlight! Oral Cancer Answers Podcast
- AAOM Members Featured in The Dermatologist Magazine
2024 © American Academy of Oral Medicine
One Glenlake Parkway, Suite 1200 • Atlanta, GA 30328
Privacy Policy
[email protected]
Phone: 571-297-4003